Updated:
Trice Medical
Trice Medical was formed with the goal of simplifying routine procedures.
Trice Medical
Trice Medical was formed with the goal of simplifying routine procedures. Its product line includes the Tenex 2nd Generation System for percutaneous tissue removal, endoscopic systems for carpal tunnel and ligament release, and a high-resolution arthroscopy platform. The firm targets tendinopathy, calcific tendonitis, bone spurs, and diabetic foot ulcers. The company manufactures and distributes these devices from two US locations: Malvern, Pennsylvania, and Lake Forest, California. Trice Medical serves hospitals and ambulatory surgery centers across the United States. Its strategy focuses on reducing procedure time and recovery for patients while expanding physician capabilities through minimally invasive techniques. The firm does not disclose professionals count, AUM, or deployment figures. No founding year or named principal wealth origin is publicly available. Trice Medical's operational posture appears centered on product commercialization rather than asset management. Trice Medical is structured as a product-development and manufacturing company rather than a traditional family office. Its model is vertically integrated — designing, producing, and selling medical devices under one roof. No information on succession structure or governance is public.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Malvern
Corporate office
Malvern, PA, United States
Additional offices
Lake Forest, CA
Sector focus
Frequently asked questions
Who runs investment decisions at Trice Medical?
Trice Medical does not publicly name its leadership or family office principals. The firm operates as a medical device company, so investment decisions likely fall to its executive team or board, but no names are disclosed (Altss research).
Is Trice Medical structured as a single family office or does it operate more like a venture firm?
Trice Medical presents as an operating company — designing, manufacturing, and selling medical devices. It does not disclose family office activity, venture investments, or fund structures. The firm's public posture is product-focused, not investment-focused (per the firm's website).
Does Trice Medical participate in fund commitments or only direct deals?
Trice Medical does not disclose any fund commitments. Its public activities center on product development and commercial sales. No direct deal activity or external investment is mentioned (per the firm's website).
What investment stages does Trice Medical typically target?
Trice Medical does not disclose investment stages or portfolio company details. The firm markets surgical devices for commercial use, suggesting a focus on product commercialization rather than early-stage or growth investing (Altss research).
Which sectors does Trice Medical explicitly avoid?
Trice Medical does not disclose investment sector exclusions. Its public focus is solely on medical devices for minimally invasive surgery, hinting at no active involvement in other sectors (per the firm's website).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: